Beijing SL Pharmaceutical Co., Ltd.

Beijing SL Pharmaceutical Co., Ltd.verified

002038.SZ

Price:

$7.87

Market Cap:

$8.09B

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; a...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2004-09-09

Stock Exchange

SHZ

Ticker

002038.SZ

The PE Ratio as of December 2025 (TTM) for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is 98.38

According to Beijing SL Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 98.38. This represents a change of 215.35% compared to the average of 31.20 of the last 4 quarters.

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) Historical PE Ratio (quarterly & annually)

How has 002038.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Beijing SL Pharmaceutical Co., Ltd. over the last ten years is 20.16. The current 98.38 PE Ratio has changed 48.71% with respect to the historical average. Over the past ten years (40 quarters), 002038.SZ's PE Ratio was at its highest in in the September 2023 quarter at 7.87K. The PE Ratio was at its lowest in in the January 2023 quarter at -576.60.

Quarterly (TTM)
Annual

Average

20.16

Median

28.40

Minimum

-106.71

Maximum

56.19

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Beijing SL Pharmaceutical Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 53.37%

Maximum Annual PE Ratio = 56.19

Minimum Annual Increase = -529.37%

Minimum Annual PE Ratio = -106.71

Quarterly (TTM)
Annual
YearPE RatioChange
2024-106.71-529.37%
202324.85-31.01%
202236.0338.17%
202126.07-8.36%
202028.451.69%
201927.98-1.28%
201828.34-49.56%
201756.1938.84%
201640.471.44%
201539.8953.37%

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) Average PE Ratio

How has 002038.SZ PE Ratio performed in the past?

The current PE Ratio of Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-15.28

5-year avg

1.74

10-year avg

20.16

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) PE Ratio vs. Peers

How is 002038.SZ’s PE Ratio compared to its peers?

Beijing SL Pharmaceutical Co., Ltd.’s PE Ratio is greater than Guizhou Xinbang Pharmaceutical Co., Ltd. (84.10), greater than Zhejiang AngLiKang Pharmaceutical CO.,LTD. (60.16), greater than China Animal Husbandry Industry Co., Ltd. (38.81), greater than Shandong Wit Dyne Health Co.,Ltd. (13.99), greater than Harbin Gloria Pharmaceuticals Co., Ltd (23.81), greater than Northeast Pharmaceutical Group Co., Ltd. (20.46), less than Nanjing Hicin Pharmaceutical Co., Ltd. (132.38), greater than Zhejiang Garden Bio-chemical High-tech Co., Ltd. (27.86), greater than Hainan Haiyao Co., Ltd. (-6.38), greater than Jiuzhitang Co., Ltd. (60.04),

Build a custom stock screener for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beijing SL Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beijing SL Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Beijing SL Pharmaceutical Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?

What is the highest PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?

What is the 3-year average PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?

What is the 5-year average PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)?

How does the current PE Ratio for Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) compare to its historical average?